News
Pfizer, Valneva Lyme vaccine starts review in Europe
After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.
News
BMS bags first approval for myeloma CELMoD Zenbexus
Bristol Myers Squibb's CELMoD pipeline has delivered its first approval, for iberdomide, as part of a combination regimen for multiple myeloma.
News
FDA cites 'significant concerns' with ADC lymphoma trial
ADC Therapeutics' chances of upgrading its accelerated approval for DLBCL therapy Zynlonta to a full approval have taken a knock.
News
MFN affecting Swiss medicines access, says Interpharma
Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.
News
ICER says AZ's new hypertension drug too expensive
ICER says that AstraZeneca's first-in-class Baxfendy and a rival drug from Mineralys are not cost-effective as therapies for resistant hypertension.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
